[
    [
        {
            "time": "2019-04-11",
            "original_text": "【科创板大阅兵】多家A股药企是客户，美迪西研发人员占总员工81%，还在招兵买马！",
            "features": {
                "keywords": [
                    "科创板",
                    "A股药企",
                    "美迪西",
                    "研发人员",
                    "招兵买马"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "【科创板大阅兵】多家A股药企是客户，美迪西研发人员占总员工81%，还在招兵买马！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "A股共发生50宗大宗交易成交16.88亿元（4月11日）",
            "features": {
                "keywords": [
                    "A股",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股共发生50宗大宗交易成交16.88亿元（4月11日）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "恒瑞医药今日大宗交易成交500万股，成交价61.79元折价3.42%",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "折价"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交500万股，成交价61.79元折价3.42%",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "上海证券市场大宗交易公开信息(2019-04-11)",
            "features": {
                "keywords": [
                    "上海证券市场",
                    "大宗交易"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海证券市场大宗交易公开信息(2019-04-11)",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "【中信建投医药】科创板系列研究之博瑞医药：技术领先的原料药、制剂一体化平台",
            "features": {
                "keywords": [
                    "中信建投",
                    "科创板",
                    "博瑞医药",
                    "原料药",
                    "制剂一体化"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "【中信建投医药】科创板系列研究之博瑞医药：技术领先的原料药、制剂一体化平台",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "医疗保健：积极关注科创+一季度高成长标的",
            "features": {
                "keywords": [
                    "医疗保健",
                    "科创",
                    "高成长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医疗保健：积极关注科创+一季度高成长标的",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "又是旧闻新炒！神秘真菌引爆A股 央视辟谣后继续大涨！概念股炒作太“不讲理”！",
            "features": {
                "keywords": [
                    "旧闻新炒",
                    "神秘真菌",
                    "A股",
                    "央视辟谣",
                    "概念股"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "又是旧闻新炒！神秘真菌引爆A股 央视辟谣后继续大涨！概念股炒作太“不讲理”！",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "西南证券：医药攻守兼备 持续推荐创新+消费+器械三大主线",
            "features": {
                "keywords": [
                    "西南证券",
                    "医药",
                    "创新",
                    "消费",
                    "器械"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "西南证券：医药攻守兼备 持续推荐创新+消费+器械三大主线",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-11",
            "original_text": "格力电器二度涨停 北上资金净买入逾10亿元",
            "features": {
                "keywords": [
                    "格力电器",
                    "涨停",
                    "北上资金",
                    "净买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格力电器二度涨停 北上资金净买入逾10亿元",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]